• OPEN AN ACCOUNT
Indian Indices
Nifty
26,186.45 152.70
(0.59%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,777.20 488.50
( 0.82%)
Nifty IT
38,703.65 343.40
( 0.90%)
Global Indices
Nasdaq
47,981.01 109.07
(0.23%)
Dow Jones
6,892.33 14.21
(0.21%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,667.01 -43.86
(-0.45%)
Forex
USD-INR
89.99 -0.14
(-0.16%)
EUR-INR
104.92 -0.11
(-0.11%)
GBP-INR
120.05 0.29
(0.24%)
JPY-INR
0.58 0.00
(0.11%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
92.66
433067.97
EPS(TTM)
Face Value()
Div & Yield %
19.48
1
0.89
 

As on: Dec 05, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,804.95 -13.65 36387 92.66
Stock Price Details
Open Price() 1,815.55
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,819.55
Today's Low () 1,800.45
52-Week High () 1910
152-Week Low () 1547.25
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.89
Eps 19.48
Book Value 99.2482659
Market Cap (.Cr) 433,067.97
Face Value 1
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE044A01036


News
Sun Pharma launches innovative drug ILUMYA (Tildrakizumab) in India
Astrazeneca Pharma and Sun Pharma form second brand partnership
Sun Pharmaceutical Industries Ltd up for fifth session
Sun Pharma records PAT of Rs 3,118 crore in Q3
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Copy of Newspaper Publication
Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter
Sun Pharmaceutical Industries Ltd up for third consecutive session
Sun Pharmaceuticals Industries to conduct board meeting
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates
More
Corporate Details
Incoporation Year   : 1993
Chairman : Dilip S Shanghvi
Bussiness Group : Sun Pharma
Registered Office
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-265-6615500
Fax:91-265-2354897
Fax:91-22-66317458
E-Mail : secretarial@sunpharma.com
URL : http://www.sunpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE SENSEX
  • BSE 100
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE GREENEX
  • bse carbonex
  • NIFTY
  • CNX 500
  • CNX 100
  • CNX Pharma
  • CNX 200
  • NI15 Index
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi